Patent details

Basic Information

Publication number:

EP3752132

PCT Application Number:

EP2019052969

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP197039951

PCT Publication Number:

WO2019158421

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITION OF BRIGATINIB

French Title of Invention:

COMPOSITION PHARMACEUTIQUE DE BRIGATINIB

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUS BRIGATINIB

SPC Number:

Dates

Filing date:

07/02/2019

Grant date:

08/12/2021

EP Publication Date:

23/12/2020

PCT Publication Date:

22/08/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/12/2021

EP B1 Publication Date:

08/12/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/02/2022

Expiration date:

07/02/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/12/2021

 

 

Name:

Sandoz AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:

MARTIN, Nolwenn

Address:

Austria (AT)

Priority

1

Priority Number:

18156509

Priority Date:

13/02/2018

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

18158053

Priority Date:

22/02/2018

Priority Country:

European Patent Office (EPO) (EP)

3

Priority Number:

18194237

Priority Date:

13/09/2018

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/14; A61K 9/19; A61K 31/506; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202149

Publication date:

08/12/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages